Diagnostic efficacy of new method for identifying pancreatobiliary tumors
Not Applicable
- Conditions
- Health Condition 1: K869- Disease of pancreas, unspecified
- Registration Number
- CTRI/2019/07/020249
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Consenting patients (or guardian) undergoing EUS guided sampling of suspected pancreato-biliary tumors
Exclusion Criteria
1) Patients on anti-platelet agents(including aspirin).
2) Patients with deranged coagulation parameters, defined by platelet counts <75,000/mm3 and/or INR >1.8
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of LBC for diagnosis of Bilio-pancreatic tumors, compared to cytology, on-site evaluation, and cell-block preparation.Timepoint: 0 hour
- Secondary Outcome Measures
Name Time Method Performance characteristics of LBC according to origin/ site of biliopancreatic tumors.Timepoint: 0 hour;Performance characteristics of LBC in relation to size of biliopancreatic tumors (2cm vs. 2cm in long axis).Timepoint: 0 hour